![Tien Li Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tien Li Lee
Oprichter bij
AARDVARK THERAPEUTICS, INC.
Vermogen: 18 M $ op 31-08-2026
Profiel
Tien Li Lee is the founder of Aardvark Therapeutics, Inc., founded in 2017, holding the titles of Chief Executive Officer & Director.
Former jobs include Director at Scilex Pharmaceuticals, Inc. from 2018 to 2023; Independent Director at Scilex, Inc. from 2019 to 2022; Independent Director at Scilex Holding Co. from 2019 to 2023; Director-Business Development at Simcere Pharmaceutical Group Ltd. from 2011 to 2013; and Chief Strategy Officer at NantKwest, Inc. from 2013 to 2017.
Education history includes undergraduate studies at the University of California, Berkeley and a doctorate from the University of California San Diego.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 08-06-2026 | 3.025.641 ( 13,83% ) | 18 M $ | 31-08-2026 |
Actieve functies van Tien Li Lee
| Bedrijven | Functie | Begin |
|---|---|---|
| AARDVARK THERAPEUTICS, INC. | Oprichter | 01-01-2017 |
Eerdere bekende functies van Tien Li Lee
| Bedrijven | Functie | Einde |
|---|---|---|
Scilex Pharmaceuticals, Inc.
 Scilex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes non-opioid pain management products | Directeur/Bestuurslid | 27-08-2023 |
| SCILEX HOLDING COMPANY | Directeur/Bestuurslid | 27-08-2023 |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Directeur/Bestuurslid | 01-11-2022 |
| IMMUNITYBIO, INC. | Corporate Officer/Principal | 01-03-2017 |
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Corporate Officer/Principal | 01-01-2013 |
Opleiding van Tien Li Lee
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
53
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology Develops and produces cancer treatment products | Health Technology |
Simcere Pharmaceutical Group Ltd.
 Simcere Pharmaceutical Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes branded generic drugs | Health Technology |
Scilex Pharmaceuticals, Inc.
Scilex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes non-opioid pain management products | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Health Technology |
Aardvark Therapeutics, Inc.
 Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases | Health Technology |
Scilex Holding Co.
 Scilex Holding Co. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales non-opioid pain management products | Health Technology |
